Siemens expects medical restructuring

Article

Add Siemens to the list of European companies planning to restructuretheir medical divisions. The German vendor announced this monththat it intends to retool its Medical Engineering Group to cometo grips with changes in healthcare in two major markets,

Add Siemens to the list of European companies planning to restructuretheir medical divisions. The German vendor announced this monththat it intends to retool its Medical Engineering Group to cometo grips with changes in healthcare in two major markets, theU.S. and Germany.

The announcement came as Siemens released year-end financialresults that indicated that the company enjoyed a healthy fiscal1996, with both revenues and profits up. Siemens warned, however,that it expected net income to be flat in 1997 due to decliningearnings in the firm's components segment, as well as an expectedrestructuring in the Medical Engineering Group.

"Earnings in the Medical Engineering Group were affectedby ongoing cost-cutting measures in the healthcare industry, particularlyin Germany and the U.S., and by sharply eroding prices,"the company said. "Additional productivity-enhancing measurescouldn't compensate for these factors."

Siemens has not yet released details on how it will restructurethe Medical Engineering Group, although it may give more informationat the upcoming Radiological Society of North America meeting,according to a spokesperson for the vendor's Siemens Medical SystemsU.S. subsidiary in Iselin, NJ.

For the year, Siemens reported revenues of 94.2 billion deutschemarks ($62.08 billion), up 6% compared with 88.8 billion DM ($58.52billion) in 1995. Net income before extraordinary items stoodat 2.49 billion DM ($1.64 billion), compared with net income of2.08 billion DM ($1.37 billion).

The medical group reported sales of 7.1 billion DM ($4.68 billion),up 4% compared with revenues of 6.8 billion DM ($4.48 billion)in fiscal 1995.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.